Cleared Traditional

K850691 - ANTISERUM TO HUMAN APOLIPOPROTEIN A-I

K850691 is the FDA 510(k) clearance for ANTISERUM TO HUMAN APOLIPOPROTEIN A-I by Kent Laboratories, Inc.. It is a Class 1 Immunology device (product code MSJ) cleared through the Traditional 510(k) pathway after a 253-day FDA review.

K850691 · Kent Laboratories, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1985
Decision
253d
Days
Class 1
Risk

K850691 is an FDA 510(k) clearance for the ANTISERUM TO HUMAN APOLIPOPROTEIN A-I. Classified as Apolipoproteins (product code MSJ), Class I - General Controls.

Submitted by Kent Laboratories, Inc. (Redmond, US). The FDA issued a Cleared decision on November 1, 1985 after a review of 253 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1475 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Kent Laboratories, Inc. devices

Submission Details

510(k) Number K850691 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 21, 1985
Decision Date November 01, 1985
Days to Decision 253 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
149d slower than avg
Panel avg: 104d · This submission: 253d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code MSJ Apolipoproteins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - MSJ Apolipoproteins

All 30
Devices cleared under the same product code (MSJ) and FDA review panel - the closest regulatory comparables to K850691.
VENTREX APO B
K861919 · Ventrex Laboratories, Inc. · Jun 1986
BIOGRAM APO A1/B
K860629 · Bio-Rad · Mar 1986
ANTISERUM TO HUMAN APOLIPOPROTEIN B
K850690 · Kent Laboratories, Inc. · Nov 1985
THROMBOSIL SILICA ACTIVATED PTT REAGENT THROMBOXIL
K851641 · Ortho Diagnostic Systems, Inc. · Jul 1985
LASER APO A-I TEST APOLIPOPROTEIN A-I REAGENTS
K850638 · Behring Diagnostics, Inc. · May 1985